Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 166,662 | 156,236 | 147,794 | 130,457 | 114,610 |
Cost of Goods | 63,574 | 62,660 | 64,851 | 61,431 | 28,747 |
Gross Profit | 103,088 | 93,576 | 82,943 | 69,026 | 85,863 |
Operating Expenses | 191,301 | 113,636 | 81,179 | 97,779 | 52,362 |
Operating Income | -87,639 | -19,400 | 2,615 | -28,322 | 34,248 |
Other Income | 2,312 | 654 | -188 | -302 | 1,873 |
Pre-tax Income | -85,327 | -18,746 | 2,427 | -28,624 | 36,121 |
Income Tax | -2,660 | -3,887 | -1,707 | -4,642 | 8,928 |
Net Income Continuous | -82,667 | -14,859 | 4,134 | -23,982 | 27,193 |
Net Income | $-82,667 | $-14,859 | $4,134 | $-23,982 | $27,193 |
EPS Basic Total Ops | -5.64 | -1.02 | 0.29 | -1.69 | 1.93 |
EPS Basic Continuous Ops | -5.64 | -1.02 | 0.29 | -1.69 | 1.93 |
EPS Diluted Total Ops | -5.64 | -1.02 | 0.28 | -1.69 | 1.89 |
EPS Diluted Continuous Ops | -5.64 | -1.02 | 0.28 | -1.69 | 1.89 |
EPS Diluted Before Non-Recurring Items | -0.30 | -0.49 | -0.02 | 0.71 | 2.05 |
EBITDA(a) | $-11,232 | $-4,913 | $23,997 | $38,744 | $40,239 |